Background: Mobile phone–based cessation interventions have emerged as a promising alternative for smoking cessation, while evidence of the efficacy of mobile phone–based smoking cessation programs among young people is mixed.
Objective: This study aimed to determine the efficacy of mobile phone–based interventions compared to usual practice or assessment-only controls on smoking cessation in young people.
Methods: In this systematic review and meta-analysis, we searched Cochrane Library, Embase, PubMed, and Web of Science on March 8, 2023. We included randomized controlled trials that examined the efficacy of mobile phone–based interventions on smoking cessation in young people (age ≤30 years). The risk of bias was assessed with Cochrane Risk of Bias 2.
Results: A total of 13 eligible studies, comprising 27,240 participants, were included in this analysis. The age range of the participants was between 16 and 30 years. Nine studies were SMS text messaging interventions, and 4 studies were app-based interventions. The duration of the smoking cessation intervention varied from 5 days to 6 months. The included studies were conducted in the following countries: the United States, China, Sweden, Canada, Switzerland, and Thailand. The meta-analysis revealed that SMS text messaging interventions significantly improved continuous abstinence rates compared to inactive control conditions (risk ratio [RR] 1.51, 95% CI 1.24-1.84). The subgroup analysis showed pooled RRs of 1.90 (95% CI 1.29-2.81), 1.64 (95% CI 1.23-2.18), and 1.35 (95% CI 1.04-1.76) for continuous abstinence at the 1-, 3-, and 6- month follow-up, respectively. Pooling across 7 studies, SMS text messaging interventions showed efficacy in promoting 7-day point prevalence abstinence (PPA), with an RR of 1.83 (95% CI 1.34-2.48). The subgroup analysis demonstrated a significant impact at the 1- and 3-month follow-ups, with pooled RRs of 1.72 (95% CI 1.13-2.63) and 2.54 (95% CI 2.05-3.14), respectively, compared to inactive control conditions. However, at the 6-month follow-up, the efficacy of SMS text messaging interventions in promoting 7-day PPA was not statistically significant (RR 1.45, 95% CI 0.92-2.28). In contrast, app-based interventions did not show significant efficacy in promoting continuous abstinence or 7-day PPA. However, it is important to note that the evidence for app-based interventions was limited.
Conclusions: SMS text messaging–based smoking cessation interventions compared to inactive controls were associated with abstinence among young people and could be considered a viable option for smoking cessation in this population. More research is needed on smoking cessation apps, especially apps that target young people. Future research should focus on identifying the most effective mobile phone–based cessation approaches and on developing strategies to increase their uptake and intention.
Trial Registration: PROSPERO CRD42022318845; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=318845
Tobacco use is one of the leading risk factors for premature morbidity and mortality worldwide . Smoking among young people is of particular concern. Despite the well-documented health risks associated with tobacco use, many young people continue to smoke or experiment with smoking. The prevalence of smoking among young people is especially troubling, as this age group is in the midst of crucial physical and psychological development. The harmful effects of smoking at this stage of life can have lifelong consequences, including increased risk of chronic disease, impaired cognitive function [ ], and reduced quality of life [ ]. In 2019, an estimated 155 million (95% uncertainty interval 150-160) people aged 15-24 years worldwide were tobacco smokers, with a prevalence of 20.1% in males and 4.95% in females [ ]. Quitting before the age of 30 years can prevent more than 97% of the excess mortality caused by continued smoking [ ]. Given the serious health risks associated with smoking, quitting is critical for young people.
While traditional cessation methods such as pharmacotherapy  and behavioral counseling [ ] can be effective, their widespread implementation at a population level faces barriers [ ]. Mobile phone–based smoking cessation interventions have emerged as a promising alternative to assist with smoking cessation [ - ]. Phone interventions are a cost-effective use of health care resources [ ]. These interventions can provide personalized interactive support that is tailored to individual needs and characteristics, irrespective of location and time constraints [ , ], making them a valuable approach for smoking cessation in this demographic. Furthermore, young individuals are more open to novel and innovative approaches [ ]. According to the International Telecommunications Union, approximately 66% of the global population had internet access in 2022 [ ]. While previous research has suggested that SMS text message–based smoking cessation interventions were more effective than minimal smoking cessation support in the general population [ ], evidence of the efficacy in young people remained inconclusive [ , ]. As countries work toward achieving the goal of reducing the prevalence of tobacco use [ ], timely data on the efficacy of mobile phone–based smoking cessation programs among young people are necessary to guide effective policy and planning.
To the best of our knowledge, there are no meta-analyses supporting the efficacy of mobile phone–based smoking cessation interventions among young people. The aim of this meta-analysis was to determine the efficacy of mobile phone–based smoking cessation interventions, excluding pharmacological treatment, in helping young smokers to quit.
We adhered to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for systematic reviews of interventions. We used a prespecified protocol registered with PROSPERO (CRD42022318845).
Search Strategy and Selection Criteria
We included randomized controlled trials (RCTs) with young smokers (30 years or younger) who wanted to quit. Included trials had to be clearly focused on smoking cessation using SMS text messaging or a smoking cessation app without pharmacotherapy, compared to a control intervention. Trials that had a focus on pregnant women were not eligible for inclusion.
Studies were assessed for inclusion if they reported cigarette smoking cessation as the primary outcome. Self-reported abstinence from cigarette smoking and biochemically validated measures of abstinence were used to define smoking cessation.
Data extracted from each study included the study location, study design, population, inclusion criteria, exclusion criteria, follow-up period, details of the intervention group, details of the control group, definition of smoking cessation, number of participants, and smoking cessation rates. Wherever possible, an intention-to-treat analysis was used.
The following electronic bibliographic databases were last searched in March 2023: Cochrane Tobacco Addiction Group’s Specialised Register (Source: PubMed, Embase, ClinicalTrials.gov, and the ICTRP), Embase, PubMed, and Web of Science. The search strategies used in the Cochrane Library, PubMed, Embase, and Web of Science are listed in. The database literature search was restricted to the English language and studies on humans. The search terms were text messaging, phone-based, smartphone, app, mobile health, sms, txt, young, student, adolescent, and smoking cessation. Both abstracts and full manuscripts were considered.
Authors XZ, XW, and AC independently confirmed study eligibility. Authors JL, YX, ZH, XX, YL, QS, and XZ extracted data, which were then checked by a second author (RQ, LZ, or AC). Two authors (XZ, AC, ZL, or ZS) independently assessed quality using the Cochrane Risk of Bias tool. All differences were resolved by discussion.
We used random-effects meta-analysis to analyze pooled outcome data among smokers who used SMS text messaging or an app compared with a control. Binary outcomes were estimated using risk ratios (RRs) and 95% CIs, with priority given to intention-to-treat data when available. For smoking cessation, meta-analyses were conducted for continuous abstinence and 7-day point prevalence abstinence (PPA). For 2 studies [, ], data specifically for individuals 30 years and younger were extracted from the original data set and reanalyzed. The 7-day PPA at the 1-month follow-up for one study was derived from the third figure in Chulasai et al [ ]. Heterogeneity between studies was assessed using the I2 statistic. A subgroup analysis of the length of follow-up was also performed. Additionally, we performed a sensitivity analysis by removing the studies with a high risk of bias. All analyses were performed using R 4.2.0 (R Foundation for Statistical Computing) and Revman 5.4 (The Cochrane Collaboration). We did not perform funnel plot asymmetry because no outcome had more than 10 studies in the meta-analysis [ ].
The risk of bias for studies was assessed using the Cochrane Risk of Bias 2 tool . Studies were considered to be at high risk in the domain of missing outcome data if the overall loss to follow-up was more than 50% or if there was a difference in follow-up rates of more than 20% between study arms.
We identified 1046 full-text trial reports or titles and abstracts () and identified 13 RCTs [ , , , , - , - ] for inclusion in the final review. The complete process is shown in .
General Characteristics of the Selected Studies
Details of the eligible studies are presented in. A total of 13 eligible studies, comprising 27,240 participants, were included in this analysis. The age range of the participants was mainly between 16 and 30 years. Of the 13 included studies, 2 were cluster RCTs [ , ] and 11 were individual RCTs. There were 5 studies in the United States [ , , , , ], 2 studies in Sweden [ , ], 2 studies in China [ , ], and 1 study each in Canada [ ], Switzerland [ ], and Thailand [ ]. One study was conducted online [ ], in which registered users of the Smoke Free app were the study participants, regardless of location. Measures of current smoking varied between studies: 4 studies [ , , , ] included daily smokers and weekly smokers, 2 studies [ , ] included only daily smokers, and Palmer et al [ ] used a definition related to daily smoking (vaping nicotine at least 25 days/month). Three studies [ , , ] included participants who smoked monthly or more, and Ybarra et al [ ] included participants who smoked 24 cigarettes or more per week (at least 4 per day on at least 6 days in a week). One study used the definition of having smoked 100 cigarettes in life and now smoking every day or some days [ ]. The remaining study [ ] did not report the definition of smoker. Of the 13 studies, 5 recruited from vocational schools [ , ], high schools [ ], or colleges [ , ]. The remaining studies recruited smokers from the community, health care facilities, online, or a combination of sources.
|Study||Participants, n||Age (years)||Intervention||Control||Outcome|
|Baskerville et al , 2018, Canada, RCT||1599||19-29||Crush the Crave Application||On the Road to Quitting–Self Help: The control group received an evidence-based self-help guide known as “On the Road to Quitting” that has been developed by Health Canada for young adult smokers.||Continuous self-reported abstinence at 6 months; self-reported 30-day PPAfrom smoking at 3 and 6 months, operationalized as not having smoked any cigarettes, even a puff, or used other tobacco in the last 30 days; self-reported 7-day PPA at 3 and 6 months.|
|Bendtsen et al , 2021, Sweden, RCT||535||High school students, median 17 (IQR 16-18)||The intervention starts with a 1-week motivational phase. After 1 week the core intervention begins and runs for 12 weeks. Participants receive up to 4 texts per day during the first few weeks, and then the number of messages per day decreases.||Self-help materials: The control group could use the website of the national quit line or contact their high school’s health service for more help||Prolonged abstinence and point prevalence of smoking cessation at the 3- and 6-month follow-ups. Prolonged abstinence, following the Russel standard, was defined at the 3-month follow-up as not smoking more than 5 cigarettes in the past 8 weeks. At 6 months, the definition was altered to not smoking more than 5 cigarettes in the past 5 months. This outcome thus measures abstinence from the start of the 12-week smoking cessation program, allowing for a 4-week grace period. Point prevalence of smoking cessation, a recommended outcome by the Society for Research on Nicotine and Tobacco, was defined as not having smoked a single cigarette in the past 4 weeks. This question measures current behavior and, thus, was the same at both the 3- and 6-month follow-ups.|
|Chulasai et al , 2022, Thailand, RCT||273||18-24||The Quit with US app integrated with smoking cessation counseling from pharmacists||Smoking cessation counseling from pharmacists||The primary smoking abstinence outcome was the 7-day point prevalence at the 12-week follow-up, as recommended for smoking abstinence measures. The outcome was defined as a self-report of the previous 7 consecutive days of continuous abstinence from smoking plus an exhaled CO concentration level of ≤6 ppm.|
|Crane et al , 2018, online, RCT||18,400||18-30||Full version of the smoke-free app||Reduced version that did not include the missions||The primary outcome measure was self-reported continuous abstinence up to the 12-week follow-up.|
|Graham et al , 2021, United States, RCT||2588||18-24||This is Quitting (texting)||Assessment only control||The primary outcome was self-reported 30-day PPA at 7 months analyzed under an intention-to-treat analysis, which counted nonresponders as vaping. Secondary outcomes were 7-day PPA under the intention-to-treat analysis and retention weighted complete case analysis of 30-day and 7-day PPA.|
|Haug et al , 2013, Switzerland, cluster RCT||755||Vocational school students, mean 18.2 (SD 2.3)||Individualized texts to support smoking cessation (2 texts per week for a period of 3 months); possibility to register for a more intensive program providing strategies for smoking cessation around a self-defined quit date (2 texts per day for a period of 4 weeks)||Assessment only control group||7-day point prevalence smoking abstinence at the 6-month follow-up (ie, not having smoked a puff within the past 7 days preceding the follow-up) and 4-week point prevalence smoking abstinence were assessed|
|Liao et al , 2018, China, RCT||344||18-30||Mobile phone–based texts (3-5 messages per day); interventions (Happy Quit) for smoking cessation for the 12-week and 24-week follow-up||No cessation message intervention: Texts every week thanking them for being in the study and texts for assessment||Biochemically verified continuous smoking abstinence at 24 weeks; self-reported 7-day PPA (ie, not even a puff of smoke, for the last 7 days) at 1, 4, 8, 12, 16, 20, and 24 weeks; self-reported continuous abstinence at 4, 12, and 24 weeks.|
|Mays et al , 2021, United States, RCT||349||18-30||6-week mobile messaging intervention||Assessments only||Self-reported cessation was assessed at 6 weeks, 3 months, and 6 months.|
|Müssener et al , 2016, Sweden, RCT||1590||Mainly between 21 and 30||Texts: Those in group 1 received motivational messages (the intervention) 5 times a day for 3 days before their stated quit day and then continue to receive 3-5 motivational texts per day for week 1, 2-4 messages per day for the next 2-4 weeks, and then 10 messages per week for the remaining 8 weeks.||Texts unrelated to quitting||At the 4-month follow-up, 8 weeks of prolonged abstinence (having smoked ≤5 cigarettes during this time); self-reported 4-week PPA (not having smoked a single cigarette); self-reported 7-day PPA (defined as not smoking any cigarettes in the past 7 days)|
|Palmer et al , 2022, United States, RCT||27||17-21||Contingency management was delivered through DynamiCare Health’s smartphone app for 4 weeks, in which financial incentives were delivered contingent on abstinent cotinine samples after the quit day until the end of treatment.||Assessment only: Control participants earned incentives for submitting cotinine, regardless of abstinence.||Abstinence at 1-month follow-up|
|Shi et al , 2013, China, cluster RCT||179||16-19||Tailored information via mobile phone texts for 12 weeks||A self-help pamphlet about smoking cessation||Self-reported 7- and 30-day abstinence at 12-week follow-up|
|Villanti et al , 2022, United States, RCT||437||18-30||12-week tailored text smoking-cessation program with a companion web-based intervention||Referral to online quit resources||Self-reported 30- and 7-day PPA at 12-week follow-up|
|Ybarra et al , 2013, United States, RCT||164||18-25||SMS USA, a 6-week smoking cessation intervention. Intervention participants received texts daily pre- and postquitting. Everyone receives messages 14 days prior to the quit day and through the day after the quit day. Then, participants are ”pathed“ to particular messages based upon their self-reported smoking status on day 2 and day 7 post quit. Those who are successful at quitting receive messages aimed at relapse prevention, whereas those who have slipped receive messages aimed at getting the person to recommit to quitting and trying again. Other name: Stop My Smoking USA||No intervention: Attention-matched control; messages aimed at improving one\'s sleep and increasing one\'s fitness, along with general messages about the most well-known health dangers of smoking. Messages sent on the same schedule as the intervention group.||Three-month continuous abstinence; smoking ≤5 cigarettes since the quit day 4 weeks post quit; 7-day PPA at 4 weeks|
aRCT: randomized controlled trial.
bPPA: point prevalence abstinence.
Most studies [, , , , , , , ] provided incentives to participants in the form of financial rewards for follow-up, with the highest incentive being US $310 [ ]. One study offered an alternative incentive in the form of a lottery draw at the end of the study instead of a monetary incentive. Nine of the selected studies provided a tailored intervention to participants [ , , , , , , - ]. These interventions were tailored to the user’s age, stage of quitting, smoking history, stage of readiness to quit, demographics, etc.
Nine studies used SMS text messaging–based interventions [, , , , , , - ], and 4 studies used app-based interventions [ , , , ]. The duration of the smoking cessation intervention varied from 5 days to 6 months, with 8 studies lasting ≥12 weeks [ , , , , , , , ], and the remaining studies lasting between 5 days and 6 weeks [ , , , , ]. Most studies used an inactive control, such as an assessment-only control group [ , , , ], SMS text messages that were unrelated to quitting [ , , ], or self-help cessation materials [ , , , ]. One study [ ] provided a reduced version app that did not include the mission. One study [ ] provided the control with smoking cessation counseling from a pharmacist. The majority of studies used self-reported abstinence, without biochemical verification. Four studies [ , , , ] used biochemically verified abstinence, such as salivary cotinine test [ , ], urine cotinine test [ ], and exhaled CO concentration for verification [ ].
Risk of Bias
The risk of bias assessments for individual studies is shown in. The majority of studies reported methods of randomization and allocation concealment that were judged to be of low risk for the randomization process. The main source of some concerns was the measurement of the outcome, as these studies used self-reported smoking cessation rates without biochemical validation, and the intervention could not be blinded to participants due to its inherent characteristics. We judged 3 studies [ , , ] to be at a high risk of bias for missing outcome data because more than 50% of participants were lost to follow-up or the difference in follow-up rates between study arms was more than 20%. The remaining studies were judged to be at a low risk in the domain of missing outcome data. Overall, 2 studies were at a low risk of bias (judged at low risk for all domains) [ , ], 3 were at high risk (judged to be at high risk in at least one domain) [ , , ], and the remaining studies were of some concern.
The result of continuous abstinence is illustrated in. Combining data from 5 studies using a random-effects meta-analysis, a significant improvement in continuous abstinence rates was observed with SMS text messaging interventions, with an RR of 1.51 (95% CI 1.24-1.84) compared with inactive control conditions (assessment only, non–quit-related SMS text messages, or self-help materials). For continuous abstinence, no high-risk study was identified when comparing the SMS text message intervention with the inactive control. The subgroup analysis ( ) showed a pooled RR of 1.90 (95% CI 1.29-2.81) for continuous abstinence at the 1-month follow-up, with no significant heterogeneity observed among the included studies. At the 3-month follow-up, the pooled RR for SMS text messaging interventions versus an inactive control was 1.64 (95% CI 1.23-2.18), with an I2 value of 50.4% (P=.089). At the 6-month follow-up, the SMS text messaging intervention yielded similar results as the 3-month follow-up for continuous abstinence (RR 1.35, 95% CI 1.04-1.76), with no significant heterogeneity observed (I2=0.0%).
Only 2 studies provided data on the RR of continuous abstinence in the comparison between app-based interventions and controls (). However, these studies yielded conflicting results. It is worth noting that both studies included in this analysis were subject to a high risk of bias due to missing outcome data.
In terms of 7-day PPA, as illustrated in, the meta-analysis of 7 studies showed an RR of 1.83 (95% CI 1.34-2.48), with an I2 value of 87% (P<.001). A sensitivity analysis excluding high-risk studies showed consistent results (RR 1.84, 95% CI 1.32-2.57; k=6), indicating the stability of the results. The subgroup analysis ( ) showed that SMS text messaging interventions had a significant impact at the 1- and 3-month follow-ups, with pooled RRs of 1.72 (95% CI 1.13-2.63) and 2.54 (95% CI 2.05-3.14), respectively, compared with inactive control conditions. When pooling across 3 studies, SMS text messaging interventions showed nonsignificant efficacy in promoting 7-day PPA at the 6-month follow-up (RR 1.45, 95% CI 0.92-2.28).
Pooling across 3 studies, app-based interventions showed no significant efficacy in promoting 7-day PPA (RR 1.27, 95% CI 0.69-2.34), indicating a lack of substantial impact (). Notably, a high level of heterogeneity was observed among the included studies, with an I2 value of 91% (P<.001), suggesting significant variation in the results. A sensitivity analysis was conducted by removing the study identified as having a high risk of bias. After the exclusion, the remaining studies showed a pooled RR of 1.86 (95% CI 1.41-2.46), indicating a relatively higher effect size in favor of app-based interventions. Importantly, the removal of the high-risk study resulted in a substantial decrease in heterogeneity, from 91% to 0%.
This study aimed to synthesize the published literature on the efficacy of mobile phone–based interventions for smoking cessation among young people. Our findings suggest that SMS text messaging interventions could be effective for smoking cessation among young individuals, whereas the evidence for app-based interventions is inconclusive. The sensitivity analysis showed stable results for SMS text messaging interventions, but conflicting results for the app-based study.
Comparison With Prior Work
Previous reviews of mobile phone–based interventions have varied considerably in terms of population characteristics [- ] and geographical limitations [ , ]. To our knowledge, there is currently no meta-analysis supporting the efficacy of mobile phone–based interventions among young people. Our review fills this gap by providing evidence that SMS text messaging approaches to smoking cessation are robust among young people. Due to the nontemporal and nonspatial nature of mobile phone–based interventions, they can reach a wider audience and serve as a good adjunct to smoking cessation interventions for this population.
The meta-analysis showed that SMS text messaging smoking cessation interventions were effective for continuous abstinence among young people, which is in line with a previous study on general smokers . The RR value at 6 months of continuous abstinence was slightly lower than that for general smokers (RR 1.54, 95% CI 1.19-2.00) [ ]. This discrepancy may be attributed to the interventions lacking specific tailoring to address the unique characteristics and needs of young individuals. Smoking cessation was related to motivation to quit, which can differ across age groups [ ]. A nationwide study conducted in the United States revealed the common reasons for smoking cessation in young adults aged 18-34 years; the two most popular reasons were physical fitness (64%) and the cost of tobacco (64%). More than half of current smokers also identified “encouragement from friend or relative” (55.2%) and “info about health hazards” (59.7%) as reasons for quitting smoking [ ]. Despite most of the included studies in our analysis allowing for customization of the quit date, the interventions’ content may not have been specifically tailored for young people. Developing more targeted cessation interventions that take into account young people’s unique motivations and use patterns is crucial. This approach may help promote a positive attitude toward quitting smoking [ ]. Furthermore, the efficacy of smoking cessation interventions among young people was observed to be slightly higher at 3 months compared to 1 month, as indicated by the 7-day PPA. This finding aligns with the cycle of withdrawal response, with the most intense withdrawal response occurring in the weeks when smokers first attempt to quit [ ].
Less than one-third of smokers use cessation medications or behavioral counseling to support quit attempts . Young smokers are more reluctant to seek treatment for smoking cessation than older smokers [ ]. Pharmacotherapy and counseling often require face-to-face contact and the presence of a health care provider, which can be time-consuming and may not be covered by insurance. Additionally, adverse drug reactions to medication can be a barrier to quitting [ ]. Young people are more likely to use mobile phones and novel technology in their daily lives [ ]. Mobile phone–based interventions can be delivered remotely and offer a more cost-effective, discreet, convenient, and accessible alternative. Therefore, mobile phone–based smoking cessation interventions are a promising alternative for young people.
In recent years, the development of technology has led to the increasing popularity of mobile phone apps designed for health management [, ]. The included studies were published between 2012-2022 for the SMS text messaging–based studies and between 2018-2022 for the app-based studies, indicating a relatively recent focus on app-based interventions. Mobile phone apps can provide more interactive and personalized features than SMS text messaging, such as tracking progress, setting goals, and sending notifications [ ]. Apps can also offer real-time support and a wealth of resources, including educational materials, coping strategies, and social support networks [ ]. However, the existing literature on app-based interventions exhibits significant heterogeneity and conflicting results. The lack of standardized protocols and guidelines for app-based smoking cessation interventions further exacerbates the challenge of generating consistent evidence. Therefore, there is a need for further research on smoking cessation apps targeted toward young people. In particular, future studies should explore the optimal features and design of smoking cessation apps.
Despite its many advantages, high dropout  and nonadherence [ ] remain significant limitations. Incentives were offered in more than half of the included trials, and these studies generally had lower dropout rates than those without incentives. The majority of included studies with incentives had loss to follow-up rates ranging from 6% to 24%, while studies without incentives had rates between 26% and 92%. We note that the study by Crane et al [ ], which was conducted in a real-world setting, reported the highest rate of missing data. This finding was in line with previous research highlighting the challenge of retaining participants in real-world studies [ ]. A review showed that the personalization of content, app design, reminder form, and personal support help to improve adherence, but research on factors that influence adherence to mobile health apps remains limited [ ]. Increasing people’s engagement and retention is important as a key consideration for such interventions on a large scale in the real world. Future research should focus on identifying the most effective design, personalized content, features, and support mechanisms to increase their uptake and intention.
Several limitations must be considered when interpreting the findings of this review. First, few studies examined app-based interventions, which limited the amount of available evidence for analysis and interpretation. Furthermore, considerable heterogeneity was observed among app-based studies. This scarcity of data highlights the need for further research in this area to improve the understanding of the efficacy of app-based interventions for smoking cessation. Second, the studies included in this review were largely conducted in high-income countries, limiting the generalizability of the findings to other settings. Lastly, a significant number of studies relied on self-reported abstinence without biochemical validation, raising some concerns in the domain of outcome measurement. In light of these limitations, future research should aim to address these issues and ensure the production of high-quality evidence to guide mobile phone–based smoking cessation interventions.
Our meta-analysis provides evidence that SMS text messaging smoking cessation interventions are effective among young people. There is a need for further research on smoking cessation apps, especially those targeted at young people. Future research should also focus on identifying the most effective mobile phone–based cessation approaches and on developing strategies to increase their uptake and intention.
This work was supported by the National High Level Hospital Clinical Research Funding (2022-NHLHCRF-LX-01-0304). The sponsor of the study had no role in the study design, collection, analysis, interpretation, or writing of this report.
All authors were involved in the planning of the study, literature review, interpretation of the findings, and manuscript preparation. DX and XZ conceived and designed the study. DX supervised the study. DX and XZ drafted the report. XZ and ZS did the statistical analysis. All authors contributed to the data collection, analysis, and interpretation. All authors revised the report and approved the final version before submission.
Conflicts of Interest
Search strategies of PubMed, Web of Science, Embase, and the Cochrane Library.DOCX File, 27 KB
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklistPDF File, 99 KB
- Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate KH. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the global burden of disease study 2015. Lancet 2017 May 13;389(10082) [CrossRef] [Medline]
- Campos MW, Serebrisky D, Castaldelli-Maia JM. Smoking and cognition. Curr Drug Abuse Rev 2016;9(2):76-79 [CrossRef] [Medline]
- Tian J, Venn AJ, Blizzard L, Patton GC, Dwyer T, Gall SL. Smoking status and health-related quality of life: a longitudinal study in young adults. Qual Life Res 2016 Mar;25(3):669-685 [CrossRef] [Medline]
- Reitsma MB, Flor LS, Mullany EC, Gupta V, Hay SI, Gakidou E. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and initiation among young people in 204 countries and territories, 1990-2019. Lancet Public Health 2021 Jul;6(7):e472-e481 [CrossRef] [Medline]
- Pirie K, Peto R, Reeves GK, Green J, Beral V, Million Women Study Collaborators. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 2013 Jan 12;381(9861):133-141 [CrossRef] [Medline]
- Shang X, Guo K, E F, Deng X, Wang Y, Wang Z, et al. Pharmacological interventions on smoking cessation: a systematic review and network meta-analysis. Front Pharmacol 2022 Oct 24;13:1012433 [CrossRef] [Medline]
- Hartmann-Boyce J, Livingstone-Banks J, Ordóñez-Mena JM, Fanshawe TR, Lindson N, Freeman SC, et al. Behavioural interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2021 Jan 4;1:CD013229 [CrossRef] [Medline]
- Adams JM. Smoking cessation-progress, barriers, and new opportunities: the surgeon general’s report on smoking cessation. JAMA 2020 Jun 23;323(24):2470-2471 [CrossRef] [Medline]
- Graham AL, Papandonatos GD, Jacobs MA, Amato MS, Cha S, Cohn AM, et al. Optimizing text messages to promote engagement with internet smoking cessation treatment: results from a factorial screening experiment. J Med Internet Res 2020 Apr 2;22(4):e17734 [CrossRef] [Medline]
- Müssener U, Bendtsen M, Karlsson N, White IR, McCambridge J, Bendtsen P. Effectiveness of short message service text-based smoking cessation intervention among university students: a randomized clinical trial. JAMA Intern Med 2016 Mar;176(3):321-328 [CrossRef] [Medline]
- Wang MP, Luk TT, Wu Y, Li WH, Cheung DY, Kwong AC, et al. Chat-based instant messaging support integrated with brief interventions for smoking cessation: a community-based, pragmatic, cluster-randomised controlled trial. Lancet Digit Health 2019 Aug;1(4):e183-e192 [CrossRef] [Medline]
- Tang J, Liao Y. Effectiveness of a text messaging-based smoking cessation intervention (Happy Quit) in China: a randomised controlled trial. Lancet 2018 Oct;392:S2 [CrossRef] [Medline]
- Daly AT, Deshmukh AA, Vidrine DJ, Prokhorov AV, Frank SG, Tahay PD, et al. Cost-effectiveness analysis of smoking cessation interventions using cell phones in a low-income population. Tob Control 2019 Jan;28(1):88-94 [CrossRef] [Medline]
- Coleman T, Clark M, Welch C, Whitemore R, Leonardi-Bee J, Cooper S, et al. Effectiveness of offering tailored text message, self-help smoking cessation support to pregnant women who want information on stopping smoking: miQuit3 randomised controlled trial and meta-analysis. Addiction 2022 Apr;117(4):1079-1094 [CrossRef] [Medline]
- Mays D, Johnson AC, Phan L, Sanders C, Shoben A, Tercyak KP, et al. Tailored mobile messaging intervention for waterpipe tobacco cessation in young adults: a randomized trial. Am J Public Health 2021 Sep;111(9):1686-1695 [CrossRef] [Medline]
- Puigdomènech E, Trujillo-Gómez JM, Martín-Cantera C, Díaz-Gete L, Manzano-Montero M, Sánchez-Fondevila J, et al. Information and communication technologies for approaching smokers: a descriptive study in primary healthcare. BMC Public Health 2015;15:2 [CrossRef] [Medline]
- ITU. Individuals using the internet. 2023. URL: www.itu.int/en/ITU-D/Statistics/Pages/stat/default.aspx [accessed 2023-08-25]
- Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y, Dobson R. Mobile phone text messaging and app-based interventions for smoking cessation. Cochrane Database Syst Rev 2019 Oct 22;10(10):CD006611 [CrossRef] [Medline]
- Baskerville NB, Struik LL, Guindon GE, Norman CD, Whittaker R, Burns C, et al. Effect of a mobile phone intervention on quitting smoking in a young adult population of smokers: randomized controlled trial. JMIR Mhealth Uhealth 2018 Oct 23;6(10):e10893 [CrossRef] [Medline]
- Bendtsen M, Bendtsen P, Müssener U. Six-month outcomes from the NEXit Junior trial of a text messaging smoking cessation intervention for high school students: randomized controlled trial with Bayesian analysis. JMIR Mhealth Uhealth 2021 Oct;9(10):e29913 [CrossRef] [Medline]
- World Health Organization. WHO framework convention on tobacco control. 2003. URL: apps.who.int/iris/handle/10665/42811 [accessed 2023-08-29]
- Liao Y, Wu Q, Kelly BC, Zhang F, Tang YY, Wang Q, et al. Effectiveness of a text-messaging-based smoking cessation intervention (“Happy Quit”) for smoking cessation in China: a randomized controlled trial. PLoS Med 2018 Dec 18;15(12):e1002713 [CrossRef] [Medline]
- Crane D, Ubhi HK, Brown J, West R. Relative effectiveness of a full versus reduced version of the ‘smoke free’ mobile application for smoking cessation: an exploratory randomised controlled trial. F1000Res 2018 Sep 21;7:1524 [CrossRef] [Medline]
- Chulasai P, Chinwong D, Vientong P, Lertsinudom S, Kanjanarat P, Hall JJ, et al. Smartphone application for smoking cessation (quit with US): a randomized controlled trial among young adult light smokers in Thailand. Int J Environ Res Public Health 2022 Jul 6;19(14):8265 [CrossRef] [Medline]
- Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011 Jul 22;343:d4002 [CrossRef] [Medline]
- Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019 Aug 28;366:l4898 [CrossRef] [Medline]
- Free C, Knight R, Robertson S, Whittaker R, Edwards P, Zhou W, et al. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet 2011 Jul 2;378(9785):49-55 [CrossRef] [Medline]
- Graham AL, Amato MS, Cha S, Jacobs MA, Bottcher MM, Papandonatos GD. Effectiveness of a vaping cessation text message program among young adult e-cigarette users: a randomized clinical trial. JAMA Intern Med 2021 Jul 1;181(7):923-930 [CrossRef] [Medline]
- Haug S, Schaub MP, Venzin V, Meyer C, John U. Efficacy of a text message-based smoking cessation intervention for young people: a cluster randomized controlled trial. J Med Internet Res 2013 Aug 16;15(8):e171 [CrossRef] [Medline]
- Mason M, Mennis J, Way T, Zaharakis N, Campbell LF, Benotsch EG, et al. Text message delivered peer network counseling for adolescent smokers: a randomized controlled trial. J Prim Prev 2016 Oct;37(5):403-420 [CrossRef] [Medline]
- Palmer AM, Tomko RL, Squeglia LM, Gray KM, Carpenter MJ, Smith TT, et al. A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth. Drug Alcohol Depend 2022 Mar 1;232:109311 [CrossRef] [Medline]
- Shi HJ, Jiang XX, Yu CY, Zhang Y. Use of mobile phone text messaging to deliver an individualized smoking behaviour intervention in Chinese adolescents. J Telemed Telecare 2013 Jul;19(5):282-287 [CrossRef] [Medline]
- Villanti AC, Peasley-Miklus C, Cha S, Schulz J, Klemperer EM, LePine SE, et al. Tailored text message and web intervention for smoking cessation in U.S. socioeconomically-disadvantaged young adults: a randomized controlled trial. Prev Med 2022 Dec;165(Pt B):107209 [CrossRef] [Medline]
- Ybarra ML, Holtrop JS, Prescott TL, Rahbar MH, Strong D. Pilot RCT results of stop my smoking USA: a text messaging-based smoking cessation program for young adults. Nicotine Tob Res 2013 Aug;15(8):1388-1399 [CrossRef] [Medline]
- Fanshawe TR, Halliwell W, Lindson N, Aveyard P, Livingstone-Banks J, Hartmann-Boyce J. Tobacco cessation interventions for young people. Cochrane Database Syst Rev 2017 Nov 17;11(11):CD003289 [CrossRef] [Medline]
- Eppes EV, Augustyn M, Gross SM, Vernon P, Caulfield LE, Paige DM. Engagement with and acceptability of digital media platforms for use in improving health behaviors among vulnerable families: systematic review. J Med Internet Res 2023 Feb 3;25:e40934 [CrossRef] [Medline]
- Gold N, Yau A, Rigby B, Dyke C, Remfry EA, Chadborn T. Effectiveness of digital interventions for reducing behavioral risks of cardiovascular disease in nonclinical adult populations: systematic review of reviews. J Med Internet Res 2021 May 14;23(5):e19688 [CrossRef] [Medline]
- Sha L, Yang X, Deng R, Wang W, Tao Y, Cao H, et al. Automated digital interventions and smoking cessation: systematic review and meta-analysis relating efficiency to a psychological theory of intervention perspective. J Med Internet Res 2022 Nov 16;24(11):e38206 [CrossRef] [Medline]
- Vijayaraghavan M, Elser H, Frazer K, Lindson N, Apollonio D. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database Syst Rev 2020 Dec 3;12(12):CD013413 [CrossRef] [Medline]
- Villanti AC, West JC, Klemperer EM, Graham AL, Mays D, Mermelstein RJ, et al. Smoking-cessation interventions for U.S young adults: updated systematic review. Am J Prev Med 2020 Jul;59(1):123-136 [CrossRef] [Medline]
- Krishnan N, Gu J, Abroms LC. Mobile phone-based messaging for tobacco cessation in low and middle-income countries: a systematic review. Addict Behav 2021 Feb;113:106676 [CrossRef] [Medline]
- Gallus S, Muttarak R, Franchi M, Pacifici R, Colombo P, Boffetta P, et al. Why do smokers quit? Eur J Cancer Prev 2013 Jan;22(1):96-101 [CrossRef] [Medline]
- Villanti AC, Bover Manderski MT, Gundersen DA, Steinberg MB, Delnevo CD. Reasons to quit and barriers to quitting smoking in US young adults. Fam Pract 2016 Apr;33(2):133-139 [CrossRef] [Medline]
- Wang T, Wang W, Liang J, Nuo M, Wen Q, Wei W, et al. Identifying major impact factors affecting the continuance intention of mHealth: a systematic review and multi-subgroup meta-analysis. NPJ Digit Med 2022 Sep 15;5(1):145 [CrossRef] [Medline]
- McLaughlin I, Dani JA, De Biasi M. Nicotine withdrawal. Curr Top Behav Neurosci 2015;24:99-123 [CrossRef] [Medline]
- US Department of Health and Human Services. Smoking cessation: a report of the surgeon general. URL: www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf [accessed 2023-08-29]
- Messer K, Trinidad DR, Al-Delaimy WK, Pierce JP. Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am J Public Health 2008 Feb;98(2):317-322 [CrossRef] [Medline]
- Gray KM, Rubinstein ML, Prochaska JJ, DuBrava SJ, Holstein AR, Samuels L, et al. High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trial. Lancet Child Adolesc Health 2020 Nov;4(11):837-845 [CrossRef] [Medline]
- Garrido S, Millington C, Cheers D, Boydell K, Schubert E, Meade T, et al. What works and what doesn’t work? A systematic review of digital mental health interventions for depression and anxiety in young people. Front Psychiatry 2019 Nov 13;10:759 [CrossRef] [Medline]
- Barroso-Hurtado M, Suárez-Castro D, Martínez-Vispo C, Becoña E, López-Durán A. Smoking cessation apps: a systematic review of format, outcomes, and features. Int J Environ Res Public Health 2021 Nov 6;18(21):11664 [CrossRef] [Medline]
- Meyerowitz-Katz G, Ravi S, Arnolda L, Feng X, Maberly G, Astell-Burt T. Rates of attrition and dropout in app-based interventions for chronic disease: systematic review and meta-analysis. J Med Internet Res 2020 Sep 29;22(9):e20283 [CrossRef] [Medline]
- Jakob R, Harperink S, Rudolf AM, Fleisch E, Haug S, Mair JL, et al. Factors influencing adherence to mHealth apps for prevention or management of noncommunicable diseases: systematic review. J Med Internet Res 2022 May 25;24(5):e35371 [CrossRef] [Medline]
- Helander E, Kaipainen K, Korhonen I, Wansink B. Factors related to sustained use of a free mobile app for dietary self-monitoring with photography and peer feedback: retrospective cohort study. J Med Internet Res 2014 Apr;16(4):e109 [CrossRef] [Medline]
|PPA: point prevalence abstinence|
|PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses|
|RCT: randomized controlled trial|
|RR: risk ratio|
Edited by Lorraine Buis; submitted 17.04.23; peer-reviewed by Firoozeh Khordastan, Hui Guo, Neelesh Mungoli, Ni Li; final revised version received 04.07.23; accepted 25.07.23; published 12.09.23Copyright
© Xinmei Zhou, Xiaowen Wei, Anqi Cheng, Zhao Liu, Zheng Su, Jinxuan Li, Rui Qin, Liang Zhao, Ying Xie, Zhenxiao Huang, Xin Xia, Yi Liu, Qingqing Song, Dan Xiao, Chen Wang. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 12.9.2023.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on https://mhealth.jmir.org/, as well as this copyright and license information must be included.